ALBA WALDENSIAN INC
SC 13D/A, 1996-01-08
KNITTING MILLS
Previous: KEMPER EUROPE FUND, N-1A, 1996-01-05
Next: ASSOCIATES CORPORATION OF NORTH AMERICA, 424B3, 1996-01-08










                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D. C. 20549

                                  SCHEDULE 13D

                    Under the Securities Exchange Act of 1934


                              ALBA-WALDENSIAN, INC.
                                (Name of Issuer)
                          Common Stock, $2.50 Par Value
                         (Title of Class of Securities)
                                    012041109
                                 (CUSIP Number)
 David Lutz, Wellco Enterprises, Inc. P. O. Box 188, Waynesvile, North Carolina
                                      28786
                                  704-456-3545
 (Name, Address and Telephone Number of person Authorized to Receive Notices and
                                 Communications)
                                December 29, 1995
             (Date of Event Which Requires Filing of this Statement)

If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  which is the subject of this  Schedule 13D, and is filing this
schedule  because of Rule 13d-1(b)(3) or (4), check the following box: [ ] Check
the  following  box if a fee is being paid with this  statement:  [ ]. (A fee is
notrequired  only if the  reporting  person:  (1) has a  previous  statement  on
filereporting  beneficial  ownership  of more than five  percent of the class of
securities  described  in Item 1;  and (2) has  filed  no  amendment  subsequent
thereto reporting beneficial ownership of five percent or less of such class.)

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 (the "Act") or otherwise  subject to the liabilities of that section of the
Act but shall be subject to all other provisions of the Act.

                               Page 1 of 11 Pages

<PAGE>



                                       13d

CUSIP NO. 012041109


1 NAME OF REPORTING PERSON'S S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
    Wellco Enterprises, Inc.
    56-0769274
2 CHECK THE APPROPRIATE BOX IF MEMBER OF A GROUP (SEE INSTRUCTIONS)
    Not Applicable (a) [ ]
                   (b) [ ]
3 SEC USE ONLY



4 SOURCE OF FUNDS (SEE INSTRUCTIONS)
    Not Applicable
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d)
    OR 2(e)
    Not Applicable
6 CITIZENSHIP OR PLACE OF ORGANIZATION
    State of North Carolina

                                   7        SOLE VOTING POWER
NUMBER OF SHARES                            -0-
BENEFICIALLY                       8        SHARED VOTING POWER
OWNED                                       -0-
BY EACH REPORTING                  9        SOLE DISPOSITIVE POWER
PERSON                                      -0-
WITH                               10       SHARED DISPOSITIVE POWER
                                            -0-

11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
        -0-
12  CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCEEDS CERTAIN SHARES (SEE
    INSTRUCTIONS)
13  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
      0%
14  TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
      CO




                               Page 2 of 11 Pages

<PAGE>



     Pursuant  to Rule  13d-1 of  Regulation  13D-G  of the  General  Rules  and
Regulations  under the Securities  Exchange Act of 1934, as amended (the "Act"),
the undersigned hereby files this Schedule 13D Statement, Amendment No. 1, dated
December 29, 1995,  relating to the Common Stock, par Value $2.50 per share (the
"Common Stock"), of Alba-Waldensian, Inc. (The "Company").

Item 5. Interest in Securities of the Issuer.

     On December  29,  1995,  the  Reporting  Person,  under a Stock  Repurchase
Agreement with The Coronet Group,  exchanged all of the 400,000 shares of Common
Stock of the Company and a cash payment of $5,460,205  for 510,424 shares of the
common  stock  of the  Reporting  Person.  In  addition,  the  Reporting  Person
relinquished  and transferred all rights and obligations it had under a December
29, 1994 Stock Purchase  Agreement  between the Reporting person and The Coronet
Group. Under the Stock Purchase Agreement, the Reporting Person had an option to
acquire up to an additional 538,700 shares of the Common Stock of the Company.

     After this  transaction the Reporting  Person does not own, either directly
or beneficially, any of the Common Stock of the Company.

     A copy of the Stock Repurchase  Agreement is attached as Exhibit 10 to this
Schedule 13D.

Signature:

     After  reasonable  inquiry and to the best of my  knowledge  and belief,  I
certify that the information  set forth in this statement is true,  complete and
correct.

January 8, 1996
WELLCO ENTERPRISES, INC.




By:   /s/ David Lutz
     David Lutz, Secretary/Treasurer



                               Page 3 of 11 Pages

<PAGE>



                                  EXHIBIT INDEX




EXHIBIT NO           DESCRIPTION                                 PAGES NUMBERED
Exhibit 1            Stock Repurchase Agreement                  5-11


                               Page 4 of 11 Pages

<PAGE>



EXHIBIT 10

STATE OF NORTH CAROLINA

COUNTY OF HAYWOOD

                                                    STOCK REPURCHASE AGREEMENT

     THIS STOCK  REPURCHASE  AGREEMENT is made and entered into this 29th day of
December,  1995,  by and between  WELLCO  ENTERPRISES,  INC.,  a North  Carolina
corporation  with its  principal  office and place of business  at 150  Westwood
Circle,  Waynesville,  North  Carolina,  and  hereinafter  referred  to  as  the
"Company"; and CLYDE Wm. ENGLE, hereinafter referred to individually as "Engle";
and the undersigned corporate signators to this Agreement,  hereinafter referred
to collectively as "The Coronet Group".

                              W I T N E S S E T H :

     WHEREAS,  The Coronet Group are  stockholders  of the Company and as of the
date of this Agreement  collectively  beneficially own a total of 535,424 shares
of the Company's presently outstanding 884,806 shares of common stock; and

     WHEREAS,  the Company is authorized  to repurchase  said shares held by The
Coronet Group pursuant to the provisions of N.C.G.S. Section 55-6-31(a); and

     WHEREAS,  the Company has received from  Interstate/Johnson  Lane, Inc., of
Charlotte,  North Carolina an opinion that the entering into of this transaction
is  fair  from a  financial  point  of view to the  common  shareholders  of the
Company,  and has given  notification of this  transaction to the American Stock
Exchange as required by the rules and regulations of said Exchange; and

     WHEREAS,  the  Board  of  Directors  of  Company  has  determined  that the
repurchase of 510,424  shares of the  Company's  stock from The Coronet Group in
accordance  with the  terms of this  Agreement  is in the best  interest  of the
Company and its common shareholders; and

     WHEREAS,  The Coronet Group are willing to sell said 510,424  shares of the
Company's stock in accordance with the terms of this Agreement;

     WHEREAS, the corporate signators to this Agreement from The Engle Group are
as  follows:  (I)  WELLCO  HOLDINGS  COMPANY,  a  Illinois  corporation,   which
beneficially owns the Company's stock which is the subject of this Agreement;

     (ii) RDIS  Corporation,  a Delaware  corporation,  of which Engle owns more
than 50% of its  outstanding  stock and  itself  is the  parent  corporation  of
SUNSTATES CORPORATION;

     (iii) SUNSTATES  CORPORATION,  a Delaware corporation,  which is the parent
corporation  of  NORMANDY   INSURANCE  AGENCY,   INC.,  an  Illinois   insurance
corporation;

     (iv) NORMANDY INSURANCE AGENCY, INC., a Illinois corporation,  which is the
parent corporation of CORONET INSURANCE COMPANY, an Illinois corporation;

     (v) CORONET INSURANCE COMPANY, an Illinois insurance corporation,  which is
the parent corporation of WELLCO HOLDINGS COMPANY, an Illinois corporation;

     (vi)  TELCO  CAPITAL  CORPORATION,  a  Delaware  corporation,  which owns a
majority  of the  equity  interest  in  HICKORY  FURNITURE  COMPANY,  a Delaware
corporation; and

                               Page 5 of 11 Pages

<PAGE>




     (vii)  HICKORY  FURNITURE  COMPANY,  a Delaware  corporation,  which owns a
majority of the equity  interest in WISCONSIN  REAL ESTATE  INVESTMENT  TRUST, a
Wisconsin business trust;

     Attached hereto as Exhibit "A" are the respective  direct beneficial owners
of the  Company's  stock which is the subject of this  Agreement  and which will
receive the payments to be made by the Company under this Agreement.  By signing
of this Agreement,  each of these named owners agree that all the  consideration
paid by the Company will be to LaSalle National Bank as payment to each of them;

     NOW  THEREFORE,  the  Company and The  Coronet  Group (by their  respective
corporate signatures  hereinafter affixed enter into this Agreement) and subject
to the following terms and conditions, hereby agree as follows:
     1. The Company  hereby  repurchases  from The Coronet Group and The Coronet
Group hereby sells to the  Company,  FIVE HUNDRED TEN THOUSAND  FOUR HUNDRED AND
TWENTY FOUR  (510,424)  shares of the  Company's  stock  currently  owned by The
Coronet  Group at a  purchase  price of  $10,346,753.00  ($20.2709  per  share),
payment to be made by a cash payment of $5,460,205.00 and transfer by Company of
the Company's 400,000 shares of the outstanding common stock of Alba-Waldensian,
Inc.,  a  Delaware  corporation,  at  an  agreed  upon  price  of  $4,886,548.00
(consisting  of the  Company's  initial  cash  cost of  $4,250,000,  the cost of
acquisition  of  $224,786,  a return on this  investment  of  $357,983,  and the
cumulative  accounting  loss  recorded by the Company of its equity share of the
losses of Alba through September 30, 1995 of $53,779),  to the respective owners
of the Company's stock  purchased  hereunder as reflected on Exhibit "A" hereto.
Payment of the above cash, transfer of the 400,000 shares of the common stock of
Alba Waldensian,  Inc. and transfer of the 510,424 shares of the Company's stock
will be made  simultaneously  and on December 29, 1995 or the earliest  possible
date thereafter.

     2. In addition to the cash purchase price for said 510,424 shares  provided
for in  Paragraph 1 above,  the Company  shall  further be  obligated to pay the
respective  owners of stock owned by The  Coronet  Group and sold to the Company
hereunder,  or their  respective  heirs,  successors  or assigns,  an additional
amount not to exceed  $1,531,272.00 but payable only from sixty (60%) percent of
the  cumulative  after-tax  profits of the Company as  determined  by the annual
audited   consolidated   financial  statements  of  the  Company  in  excess  of
$400,000.00 for each of the six (6) fiscal years of the Company  commencing with
the fiscal  year  starting  June 30,  1996.  Such  payment  shall be made by the
Company  within ten (10) days after the  receipt by the  Company of its  audited
financial statement for its fiscal year ending June 28, 1997, and the subsequent
five (5) fiscal years,  until the selling  shareholders  have  collectively been
paid a maximum total of $1,531,272.00. Said audited financial statement shall be
furnished to the Company by the  Company's  then-regularly  engaged  independent
auditors.  The Company  shall have the right at any time to prepay the principal
of any unpaid balance of the maximum $1,531,272.00,  in whole or in part, at its
discounted  present Value  applying a SEVEN (7.0%) PERCENT  discount  factor per
annum from its execution date to the prepayment date and assuming a total payout
period of six (6) years from June 30, 1996. Said  obligation  shall be unsecured
and subordinate to all financial  obligations of the Company for money borrowed,
whether now or hereafter secured or unsecured and no payments on said obligation
may be made if there then exists any default in the terms of any such secured or
unsecured  financial  obligations  of the Company and said  obligation  shall be
subordinate  to such  other  secured or  unsecured  financial  obligations.  The
Company  will  expeditiously  prepare a  Contingent  Note  containing  the above
provisions.

     3. The Coronet  Group  hereby  warrant,  acknowledge  and  represent to the
Company that the report of beneficial  ownership of the Company's  stock held by
The  Coronet  Group as reported  in SEC Form 4 for the month of  November,  1995
attached  hereto as Exhibit "B" and filed with the United States  Securities and
Exchange  Commission  and the Company,  is and remains true and correct and that
the identity and respective stock holdings of the Company's stock of the Coronet
Insurance Company subsidiaries not named in Exhibit "B" are as stated in Exhibit
"A" hereto.



                               Page 6 of 11 Pages

<PAGE>



     4. The Coronet Group hereby warrants and represents to the Company that The
Coronet  Group is  acquiring  said shares of Alba  Waldensian,  Inc. for its own
account, for the purpose of investment only and not for the purpose of or with a
view to the  sale  or  other  disposition  thereof  within  the  meaning  of the
Securities  Act of 1933,  as amended (the "Act"),  except as may be permitted by
such Act and the rules and regulations  promulgated  under such Act. The Coronet
Group  acknowledges that said shares are not registered with the SEC or with any
regulatory  agencies charged with the  administration  of state securities laws.
The Coronet  Group  acknowledges  that a legend to such effect will be placed on
certificates  representing the shares.  As a condition to said purchase and sale
transaction,  the Company hereby relinquishes and transfers to The Coronet Group
all  rights  and  obligations  of the  Company  and  The  Coronet  Group  hereby
relinquishes  and  transfers  to the Company all rights and  obligations  of The
Coronet Group arising under December 29, 1994 Stock Purchase  Agreement  between
the Company and Coronet  Insurance  Company  relating to said 400,000  shares of
Alba-Waldensian, Inc. stock which were subject of said Stock Purchase Agreement.
Accordingly,  upon transfer of said  Alba-Waldensian  shares said Stock Purchase
Agreement shall become null and void and no longer of any force and effect by or
against the Company and The Coronet Group.

     5. The Coronet  Group  hereby  irrevocably  agree that neither they nor any
person,  firm or  corporation  with which  they are  associated  (as  defined by
applicable  rules and  regulations of the United States  Securities and Exchange
Commission) will acquire direct or indirect  beneficial  ownership of any of the
Company's common stock exceeding 20% of the common stock outstanding at any time
for a period of ten (10) years after the  consummation  of this  Agreement.  The
Coronet Group hereby irrevocably designate the Board of Directors of the Company
as  their  attorney-in-fact  and  proxy  for this ten  (10)  year  period  after
consummation of this purchase  transaction as to the voting rights  attendant to
all shares of the Company's stock now or hereafter owned by The Coronet Group at
any annual or special  meeting of the Company's  stockholders  as to any and all
matters which may properly come before the  Company's  stockholders  for vote at
all of said meetings.

     6.  Clyde  Wm.  Engle  further  hereby  irrevocably  agrees  to resign as a
Director of the Company  effective  with said  consummation  of this  repurchase
transaction as above provided.

     7. The Coronet  Group hereby  undertake to timely file with the  Securities
and  Exchange  Commission  all  filings  required  by  them  as  the  result  of
consummation of this Agreement and particularly SEC Form 4 and Form 13-D.

     8. The Coronet  Group  warrants and  represents to the Company that each of
the corporate  members of The Engle Group which are signators to this  Agreement
and the  individual  signators  signing on their  respective  behalves have full
corporate,  statutory and regulatory  authority to execute and  consummate  this
Agreement  and that the  Company's  stock to be sold to the Company  pursuant to
this  Agreement  will be at closing  hereunder  free of any liens or contractual
obligations of them or any of them that would preclude or in any manner restrict
or limit the sale of the Company's stock pursuant to this Agreement.

     9. Attached  hereto as Exhibit "C" is a schedule of all the Company's stock
acquired  by The  Coronet  Group  acquired  by them after June 30,  1995 and the
respective  purchase price for said stock so acquired.  The Coronet Group hereby
acknowledge  that they are  respectively  liable to the  Company  for any profit
realized by them based upon the selling price of $20.2709 per share provided for
under  Paragraph 1 of this  Agreement  and the purchase  price for said stock as
reported on said Exhibit "C". The Coronet  Group as reported on said Exhibit "C"
shall  pay to the  Company  upon the  Company's  purchase  of the  stock  hereby
repurchased by the Company the profit realized  pursuant to Section 16(d) of the
Securities Exchange Act of 1934, on or before January 31, 1996.



                               Page 7 of 11 Pages

<PAGE>



     10. This Agreement shall be interpreted  under applicable laws of the State
of North  Carolina  and the United  States of  America.  All notices to be given
hereunder shall be mailed (with facsimile copies thereof) as follows:

To The Coronet Group:                       To the Company:
c/o Sunstates Corporation                   Mr. Horace Auberry
4600 Marriott Dr.                           Chairman, Board of Directors
Raleigh, NC 27612                           Wellco Enterprises, Inc.
                                            Post Office Box 188
                                            Waynesville, NC  28786
Fax No: 919-781-5619                        Fax No:         (704) 456-3547



                               Page 8 of 11 Pages

<PAGE>



     This  Agreement  has been  executed and entered into by the Chairman of the
Board of the  Company  upon  authorization  duly  given to them by the  Board of
Directors of the Company at a Special Meeting thereof held on December 29, 1995,
and by the undersigned corporate members of The Coronet Group.


                                 BY AUTHORIZED OFFICER              SIGNATURE
WELLCO ENTERPRISES, INC.         Chairman of the Board of
                                 Directors
THE CORONET GROUP:
WELLCO HOLDINGS
COMPANY
NATIONAL ASSURANCE
INDEMNITY COMPANY
CORONET INSURANCE
COMPANY
NORMANDY INSURANCE
AGENCY
SUNSTATES CORPORATION
WISCONSIN REAL ESTATE
INVESTMENT FUND
HICKORY FURNITURE
COMPANY
TELCO CAPITAL
CORPORATION
RDIS CORPORATION
CLYDE WM. ENGLE,
individually and as a Director
of the Company







                               Page 9 of 11 Pages

<PAGE>



EXHIBIT A
STOCK REPURCHASE AGREEMENT ENTERED INTO ON DECEMBER 29, 1995
BETWEEN WELLCO ENTERPRISES, INC. AND THE CORONET GROUP
DIRECT BENEFICIAL OWNERS OF THE COMPANY'S STOCK SUBJECT TO THIS AGREEMENT




Wellco Holdings Company

National Assurance Indemnity Company

Coronet Insurance Company

Normandy Insurance Agency

Sunstates Corporation

Wisconsin Real Estate Investment Fund

Hickory Furniture Company

Telco Capital Corporation

RDIS Corporation

Clyde Wm. Engle

















                               Page 10 of 11 Pages

<PAGE>



EXHIBIT B
STOCK REPURCHASE AGREEMENT ENTERED INTO ON DECEMBER 29, 1995
BETWEEN WELLCO ENTERPRISES, INC. AND THE CORONET GROUP
SECURITIES AND EXCHANGE COMMISSION FORM 4 OF THE CORONET GROUP FOR NOVEMBER,
1995





The  attached  eight  pages  are a true and  exact  copy of the  Securities  and
Exchange Commission Form 4 for The Coronet Group.




                               Page 11 of 11 Pages

<PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission